Research publications

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005

Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, et al; QUEST Study Group

(2007), Clin Infect Dis, 45(3), 381-90

Reliability and validity of the Kessler 10 and Patient Health Questionnaire among injecting drug users

Hides L, Lubman DI, Devlin H, Cotton S, Aitken C, Gibbie T, Hellard M

(2007), Aust N Z J Psychiatry, 41(2), 166-8

Large outbreak of infection and colonization with gram-negative pathogens carrying the metallo- beta -lactamase gene blaIMP-4 at a 320-bed tertiary hospital in Australia

Herbert S, Halvorsen DS, Leong T, Franklin C, Harrington G, Spelman D

(2007), Infect Control Hosp Epidemiol, 28(1), 98-101

Tattooing in prisons--not such a pretty picture

Hellard ME, Aitken CK, Hocking JS

(2007), Am J Infect Control, 35(7), 477-80

HIV diagnoses in Australia: diverging epidemics within a low-prevalence country

Guy RJ, McDonald AM, Bartlett MJ, Murray JC, Giele CM, Davey TM, Appuhamy RD, Knibbs P, Coleman D, Hellard ME, Grulich AE, Kaldor JM

(2007), Med J Aust, 187(8), 437-40

A new surveillance system for monitoring HIV infection in Victoria, Australia

Guy R, Lim MS, Wang YH, Medland N, Anderson J, Roth N, Hellard ME

(2007), Sex Health, 4(3), 195-9

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo

Gorry PR, McPhee DA, Verity E, Dyer WB, Wesselingh SL, Learmont J, Sullivan JS, Roche M, Zaunders JJ, Gabuzda D, Crowe SM, Mills J, Lewin SR, Brew BJ, Cunningham AL, Churchill MJ

(2007), Retrovirology, 4, 66

Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote

Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, Moore JP, Mascola JR, Agopian K, Holm GH, Mehle A, Taylor J, Farzan M, Wang H, Ellery P, Willey SJ, Clapham PR, Wolinsky SM, Crowe SM, Gabuzda D

(2007), Virology, 362(1), 163-78

Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo

Gorry PR, Churchill M, Learmont J, Cherry C, Dyer WB, Wesselingh SL, Sullivan JS

(2007), J Acquir Immune Defic Syndr, 46(4), 390-4

Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy

Goller JL, Jolley D, Ringwald P, Biggs BA

(2007), Am J Trop Med Hyg, 76(2), 203-7

The feasibility of recruiting young men in rural areas from community football clubs for STI screening

Gold J, Hocking J, Hellard M

(2007), Aust N Z J Public Health, 31(3), 243-6

What are the barriers to offering HIV testing in an antenatal setting? A national study of obstetricians

Giles ML, Garland SM, Lewin SR, Hellard ME

(2007), AIDS, 21(12), 1601-6

Influence of IFN? Co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy

Emery S, Kelleher AD, Workman C, Puls RL, Bloch M, Baker D, Anderson J, Hoy J, Ip S, Nalliah K, Ward LD, Law MG, Cooper DA

(2007), Human Vaccines, 3(6), 260-7

The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo

Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, Sonza S, Crowe SM

(2007), J Immunol, 178(10), 6581-9

Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples

Dyer WB, Pett SL, Sullivan JS, Emery S, Cooper DA, Kelleher AD, Lloyd A, Lewin SR

(2007), Clin Vaccine Immunol, 14(1), 52-9

Human immunodeficiency virus-associated progressive multifocal leucoencephalopathy: epidemiology and predictive factors for prolonged survival

Drake AK, Loy CT, Brew BJ, Chen TC, Petoumenos K, Li PC, Wright EJ

(2007), Eur J Neurol, 14(4), 418-23

AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation--treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A

Dawson MA, Schwarer AP, McLean C, Oei P, Campbell LJ, Wright E, Shortt J, Street AM

(2007), Haematologica, 92(1), e11-2

The Sydney Declaration: a call to scale up research

Cooper D, Cahn P, Lewin S, Kaldor J, McClure C, Kort R, Boyd M

(2007), Lancet, 370(9581), 7-8

Infection with Scedosporium apiospermum and S. prolificans, Australia

Cooley L, Spelman D, Thursky K, Slavin M

(2007), Emerg Infect Dis, 13(8), 1170-7

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Clotet B, Bellos N, Molina JM, Cooper D, Goffard JC, Lazzarin A, Wöhrmann A, Katlama C, Wilkin T, Haubrich R, Cohen C, Farthing C, Jayaweera D, Markowitz M, Ruane P, Spinosa-Guzman S, Lefebvre E; POWER 1 and 2 study groups

(2007), Lancet, 369(9568), 1169-78

Publication Details